Skip to main content
. Author manuscript; available in PMC: 2011 Oct 19.
Published in final edited form as: J Clin Endocrinol Metab. 2006 Aug 29;91(11):4438–4444. doi: 10.1210/jc.2006-1174

TABLE 1.

Baseline clinical characteristics

Placebo
(n = 12)		 Acipimox
(n = 11)		 P value
Age (yr) 46 (3) 45 (2) 0.7
Sex (male/female) 8/4 9/2 0.4
Duration HIV (yr) 11 (1) 11 (1) 0.8
Current PI use (n) 8 4 0.1
PI (months) 54 (9) 43 (14) 0.5
CD4 T cell count (cells/mm3) 417 (95) 428 (61) 0.9
BMI (kg/m2) 24 (1) 29 (2) 0.01

Values represent mean (SEM); P values represent result of Student’s t test between groups, except for categorical variables in which χ2 statistics were used. PI, Protease inhibitor.